Abdul Rafae
Impact in
- Hematology top 10%
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
-
- Peptidase Inhibition and Analysis
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
Papers in
- Hematology 20
- Multiple Myeloma Research and Treatments 15
- Oncology 14
- Peptidase Inhibition and Analysis 4
- Cancer Treatment and Pharmacology 2
- Co-authors
- Hamid Ehsan (11 shared papers)Ahsan Wahab (11 shared papers)Faiz Anwer (23 shared papers)Kamran Mushtaq (3 shared papers)Seren Durer (7 shared papers)Ceren Durer (7 shared papers)Ahmad Kamal (6 shared papers)Sarah Lee (1 shared paper)
- Journals
- Blood (10 papers)Journal of Clinical Oncology (3 papers)Blood Reviews (2 papers)OncoTargets and Therapy (1 paper)Expert Review of Anticancer Therapy (1 paper)
- Partner nations
- United StatesPakistanIndia
In The Last Decade
Abdul Rafae
29 papers receiving 252 citations
Peers
Comparison fields: 5 of 63
- Hematology 133
- Oncology 119
- Genetics 38
- Transplantation 5
- Radiology, Nuclear Medicine and Imaging 33
Countries citing papers authored by Abdul Rafae
This map shows the geographic impact of Abdul Rafae's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdul Rafae with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdul Rafae more than expected).
Fields of papers citing papers by Abdul Rafae
This network shows the impact of papers produced by Abdul Rafae. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdul Rafae. The network helps show where Abdul Rafae may publish in the future.
Co-authors
The 25 scholars most cited alongside Abdul Rafae, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 60 | |
| 2 | 2019 | 42 | |
| 3 | 2020 | 41 | |
| 4 | 2018 | 20 | |
| 5 | 2015 | 17 | |
| 6 | 2022 | 10 | |
| 7 | 2019 | 7 | |
| 8 | 2021 | 7 | |
| 9 | 2022 | 6 | |
| 10 | 2021 | 6 | |
| 11 | 2021 | 5 | |
| 12 | 2022 | 4 | |
| 13 | 2022 | 3 | |
| 14 | 2021 | 3 | |
| 15 | 2019 | 3 | |
| 16 | 2020 | 3 | |
| 17 | 2020 | 2 | |
| 18 | 2022 | 2 | |
| 19 | 2018 | 2 | |
| 20 | 2020 | 2 |
About Abdul Rafae
Abdul Rafae is a scholar working on Hematology, Oncology, Molecular Biology, Genetics and Pulmonary and Respiratory Medicine, having authored 34 papers that have together received 256 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (15 papers), Protein Degradation and Inhibitors (9 papers), Peptidase Inhibition and Analysis (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Cancer Treatment and Pharmacology (2 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers). The work is most often cited by research in Hematology (133 citations), Oncology (119 citations), Genetics (38 citations), Transplantation (5 citations) and Radiology, Nuclear Medicine and Imaging (33 citations). Abdul Rafae has collaborated with scholars based in United States, Pakistan and India. Frequent co-authors include Hamid Ehsan, Ahsan Wahab, Faiz Anwer, Kamran Mushtaq, Seren Durer, Ceren Durer, Ahmad Kamal, Sarah Lee, Abdul Qayyum and Asim Karim. Their work appears in journals such as Blood, Journal of Clinical Oncology, Blood Reviews, OncoTargets and Therapy and Expert Review of Anticancer Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.